token,surprisal
##,9.906425476074219
 Hyper,18.333677291870117
gly,11.823946952819824
cemic,3.0686850547790527
 conditions,10.348161697387695
 are,3.920541524887085
 associated,3.4992311000823975
 with,0.010803453624248505
 sodium,13.533750534057617
 retention,4.410180568695068
 in,2.232391119003296
 chronic,9.423526763916016
 kidney,3.709160327911377
 disease,0.4073852300643921
"
",5.424409866333008
"
",0.005662447772920132
Hyper,4.873376846313477
gly,0.04727883264422417
ce,2.135918140411377
mia,7.533036841778085e-05
 is,1.6482336521148682
 associated,2.0334091186523438
 with,0.005037298426032066
 increased,3.052048683166504
 mortality,5.752289772033691
 in,2.0216104984283447
 patients,3.0374886989593506
 with,0.3456047773361206
 chronic,2.507274866104126
 kidney,0.38301631808280945
 disease,0.021012311801314354
 (,2.598752021789551
C,4.757011413574219
K,0.6265203952789307
D,0.311393678188324
).,2.2757904529571533
 It,5.370140075683594
 has,3.487637519836426
 been,0.370164155960083
 proposed,4.262310981750488
 that,0.09448188543319702
 this,6.306484699249268
 increased,5.672830104827881
 mortality,0.7998642325401306
 may,1.885319471359253
 be,0.7831366658210754
 related,4.27132511138916
 to,0.025294840335845947
 volume,14.44439697265625
 overload,8.635616302490234
.,3.8547611236572266
 In,3.7361021041870117
 hyper,8.771289825439453
gly,0.07832873612642288
ce,0.6296097636222839
mia,0.0044793556444346905
",",0.6688733696937561
 glucose,7.130677223205566
 is,2.1658425331115723
 filtered,14.159689903259277
 by,5.511899948120117
 the,1.2651610374450684
 kidneys,1.4116542339324951
 and,1.84259831905365
 then,4.546648979187012
 re,6.974438667297363
absor,0.22796860337257385
bed,0.003090137615799904
 by,2.23742938041687
 the,0.5211231112480164
 prox,10.856698989868164
imal,0.0012869180645793676
 tub,5.015472888946533
ules,0.5462303757667542
.,1.7057300806045532
 The,3.010188341140747
 sodium,5.205422878265381
-,6.307171821594238
gl,6.553927421569824
uc,0.13018497824668884
ose,0.023511042818427086
 co,11.816802978515625
-,2.6479036808013916
trans,4.766796112060547
porter,1.978898048400879
 (,3.570547580718994
S,1.1672335863113403
GL,1.6459540128707886
T,2.352635145187378
),0.23570583760738373
 family,9.812982559204102
 is,2.666934013366699
 responsible,2.8673348426818848
 for,0.009019041433930397
 this,5.382157325744629
 re,6.069999694824219
absor,0.04747477546334267
ption,0.03794323280453682
 of,2.368464469909668
 glucose,3.2277157306671143
.,1.5655522346496582
 In,3.3878581523895264
 chronic,5.04325532913208
 kidney,0.3187434673309326
 disease,0.02221611887216568
",",0.508031964302063
 these,5.961886882781982
 S,4.546898365020752
GL,0.019628359004855156
Ts,2.2748513221740723
 are,1.8231959342956543
 also,5.679188251495361
 expressed,6.084043025970459
 in,0.6766622066497803
 the,1.0641206502914429
 dist,6.850877285003662
al,0.01596301980316639
 tub,1.802120566368103
ule,4.341976642608643
.,2.4225761890411377
 It,5.76430082321167
 was,3.8480453491210938
 shown,2.15482234954834
 that,0.37390199303627014
 hyper,4.105258464813232
gly,0.011090426705777645
ce,0.10490024834871292
mia,0.0006269269506447017
 increases,4.877064228057861
 sodium,3.7090306282043457
 re,8.633492469787598
absor,0.027051318436861038
ption,0.006307905074208975
 in,1.8819313049316406
 patients,4.001742362976074
 with,0.17099368572235107
 CK,0.4438000023365021
D,0.005727196112275124
 via,10.133249282836914
 the,2.5624003410339355
 S,2.4205527305603027
GL,0.08699384331703186
T,0.04094081372022629
2,9.012115478515625
/,4.685545444488525
N,7.943520545959473
HE,9.975851058959961
3,7.430080890655518
 system,5.4899983406066895
 located,11.831432342529297
 in,1.1273934841156006
 the,0.2660537362098694
 dist,3.417201042175293
al,0.004145659040659666
 convoluted,14.668401718139648
 tub,1.3548130989074707
ules,1.7022254467010498
 and,4.140034198760986
 collecting,18.370954513549805
 duct,14.808537483215332
s,0.4136124551296234
.,1.0939996242523193
"
",3.6323180198669434
"
",0.0003413399390410632
####,13.13784122467041
##,0.6438331007957458
 Pot,9.745180130004883
assium,0.24616414308547974
 levels,7.932289123535156
 are,2.1654326915740967
 not,5.545377254486084
 significantly,5.440853595733643
 different,2.079357862472534
 in,2.2558178901672363
 hyper,5.259468078613281
gly,0.014973628334701061
cemic,1.1191126108169556
 conditions,1.9391356706619263
"
",1.7068758010864258
"
",0.0004460199561435729
Pot,2.543767213821411
assium,0.00220142281614244
 metabolism,8.291566848754883
 is,1.0992987155914307
 affected,5.563859939575195
 by,0.2621852457523346
 chronic,6.452811241149902
 kidney,0.3531126081943512
 disease,0.015995189547538757
 with,7.876236915588379
 potassium,5.875165939331055
 retention,3.7438035011291504
 in,2.4459471702575684
 the,2.688390016555786
 presence,7.957890510559082
 of,0.1778087615966797
 diminished,14.227081298828125
 gl,11.247418403625488
omer,0.3712823688983917
ular,0.12662620842456818
 fil,0.23272569477558136
t,0.03079996630549431
ration,6.673081225017086e-05
 rate,5.470932483673096
 (,1.6099308729171753
G,2.1386971473693848
FR,0.24453383684158325
).,1.2948861122131348
 However,6.07515287399292
",",0.00918856542557478
 hyper,4.71976900100708
gly,0.06530867516994476
ce,0.24883559346199036
mia,0.0006329489988274872
 does,2.9132134914398193
 not,0.07267992198467255
 seem,6.686857223510742
 to,0.021815873682498932
 have,3.9223711490631104
 a,1.8324006795883179
 direct,5.143092632293701
 impact,3.171577215194702
 on,0.050368111580610275
 potassium,1.6709398031234741
 levels,3.344682216644287
.,1.4596643447875977
 This,5.564569473266602
 may,3.259582042694092
 be,0.47525754570961
 explained,5.780093669891357
 by,0.1982637196779251
 the,1.0784790515899658
 fact,2.191002130508423
 that,0.011027082800865173
 potassium,4.086080074310303
 regulation,11.170711517333984
 is,1.3145737648010254
 controlled,6.371800899505615
 via,4.602239608764648
 the,1.7710157632827759
 ren,11.922070503234863
in,0.05412515252828598
-,1.1734952926635742
ang,3.4099202156066895
iot,0.03466601297259331
ens,0.015308361500501633
in,0.004475646652281284
-,2.967885971069336
ald,10.062206268310547
osterone,0.08526916801929474
 system,1.7361825704574585
.,2.0103557109832764
"
",2.6616249084472656
"
",0.0002732202992774546
In,4.532018184661865
 conclusion,7.065981864929199
",",0.09472786635160446
 patients,7.3870930671691895
 with,0.17313608527183533
 diabetes,8.434784889221191
 mell,3.8611040115356445
itus,0.0014190386282280087
 and,4.513433933258057
 CK,2.825807571411133
D,0.0027286759577691555
 are,3.240797519683838
 at,1.6474512815475464
 high,4.89349365234375
 risk,0.017955070361495018
 for,0.5290551781654358
 hyper,2.790415048599243
gly,0.015756532549858093
ce,0.17362773418426514
mia,0.00027597256121225655
 which,8.338093757629395
 will,7.445714473724365
 increase,4.002548694610596
 sodium,3.8415884971618652
 re,4.045158863067627
absor,0.0030392087064683437
ption,0.0021857486572116613
 but,8.422179222106934
 will,3.597031593322754
 not,1.157272458076477
 impact,7.978468418121338
 significantly,13.374695777893066
 on,0.9586119055747986
 potassium,1.1999318599700928
 levels,1.0992577075958252
.,0.3128524422645569
"
",1.8545631170272827
"
",0.0003533816197887063
####,2.6011106967926025
##,0.3713698983192444
 B,8.556767463684082
ibliography,6.6983489990234375
:,2.6872663497924805
"
",0.5463467836380005
"
",0.00030280722421593964
1,3.782038688659668
.,0.5038394927978516
 G,6.686102867126465
av,7.719125270843506
azz,5.077425479888916
i,0.5952122211456299
 A,4.7707109451293945
 et,5.097879409790039
 al,0.0011233119294047356
.,0.31543564796447754
 Effect,7.0124616622924805
 of,0.05297079309821129
 Hyper,9.633448600769043
gly,0.02926916815340519
ce,0.45360156893730164
mia,0.0008880476816557348
 on,0.33423396944999695
 Sodium,2.112961769104004
 and,4.641190528869629
 Pot,1.8723275661468506
assium,1.6854397472343408e-05
 Levels,4.6874847412109375
 in,0.6119133234024048
 Patients,2.5439536571502686
 With,1.4367175102233887
 CK,4.64113712310791
D,0.0005889027961529791
.,0.8789082765579224
 Neph,9.364861488342285
rol,0.6937139630317688
 Dial,3.6078813076019287
 Trans,3.9620931148529053
plant,0.2013290673494339
.,1.8898439407348633
 2020,12.93303108215332
;,1.0596938133239746
35,6.863301753997803
(,0.7092001438140869
8,4.69712495803833
):,0.08296287804841995
12,4.410158634185791
87,6.815746307373047
-,0.45199644565582275
94,5.044811248779297
.,0.14786124229431152
 doi,3.520272731781006
:,0.01667686551809311
 10,0.7297678589820862
.,0.005528297740966082
10,3.231032371520996
93,2.73348069190979
/,0.0012598929461091757
nd,6.830757141113281
t,6.027563095092773
/,0.7767014503479004
g,6.171217441558838
f,8.986095428466797
z,8.822319984436035
614,14.126338958740234
"
",2.49580454826355
2,21.93628692626953
.,0.0011762387584894896
 Wang,9.326896667480469
 R,5.518961429595947
 et,0.4454261362552643
 al,0.0026066007558256388
.,0.007837604731321335
 Mechan,9.11947250366211
isms,0.3956933617591858
 of,0.8596872687339783
 sodium,4.279673099517822
 retention,1.3480983972549438
 in,0.49846357107162476
 diabetes,6.134438991546631
 mell,0.2982087731361389
itus,0.00020708197553176433
 and,2.734670400619507
 chronic,4.239096641540527
 kidney,0.5242348909378052
 disease,0.02426842413842678
.,0.5580135583877563
 Kid,6.46233606338501
ney,0.04119774326682091
 Int,2.111604928970337
 Rep,11.43096923828125
.,1.3754265308380127
 2019,8.878737449645996
;,0.1326005905866623
4,6.220130920410156
(,0.6808553338050842
3,2.7988991737365723
):,0.03778539225459099
479,10.732282638549805
-,0.07130651921033859
85,6.597297668457031
.,0.09669393301010132
 doi,0.26836535334587097
:,0.001849826890975237
 10,0.015529735013842583
.,0.0018171947449445724
1016,2.4428489208221436
/,0.0007580406963825226
j,0.0808979943394661
.,0.000661080761346966
ek,17.23717498779297
ir,4.241888999938965
.,1.1370073556900024
2018,0.6090474128723145
.,0.003188295057043433
12,3.802236795425415
.,0.0010798531584441662
001,3.4983644485473633
"
",0.507776141166687
"
",0.0010183246340602636
#,12.777588844299316
 INST,16.855562210083008
"
",9.871160507202148
"
",0.00039793673204258084
1,4.935314655303955
.,0.20357415080070496
 What,12.218210220336914
 happens,7.511112213134766
 to,1.4400814771652222
 the,2.6052396297454834
 potassium,2.7372794151306152
 level,4.438202857971191
 during,6.013432502746582
 metabolic,8.973541259765625
 acid,4.6638031005859375
osis,0.1995444893836975
?,0.7491330504417419
"
",0.675241231918335
2,22.616315841674805
.,0.00143083103466779
 What,4.654350280761719
 would,9.23203182220459
 be,2.737658977508545
 a,5.4978814125061035
 major,6.135880947113037
 consequence,6.070478439331055
 of,0.4063199460506439
 chronic,5.987246036529541
 hyper,3.7942302227020264
k,11.368022918701172
al,0.08756306767463684
emia,0.014103789813816547
?,0.8342441916465759
"
",0.20033280551433563
3,22.123668670654297
.,0.001177099416963756
 What,2.34470272064209
 is,1.9480865001678467
 the,0.8868393898010254
 difference,7.746240139007568
 between,0.10022950917482376
 metabolic,6.5659403800964355
 alk,6.828686237335205
al,0.3169878423213959
osis,0.30223214626312256
 and,0.49406152963638306
 respiratory,11.805373191833496
 alk,0.7471324801445007
al,0.01733214408159256
osis,0.0036848727613687515
?,0.24333719909191132
"
",0.16267071664333344
4,20.152833938598633
.,0.0013449291000142694
 What,1.9638354778289795
 is,1.229384183883667
 an,5.210047721862793
 appropriate,6.9473981857299805
 medication,9.764603614807129
 for,0.6925195455551147
 treating,5.893806457519531
 hyper,2.0285098552703857
cal,5.916979789733887
ce,0.4275391697883606
mia,0.00018661325157154351
?,0.2737174928188324
"
",0.18545137345790863
5,20.31681251525879
.,0.001289155799895525
 Which,6.174236297607422
 substance,12.859532356262207
 is,2.0090670585632324
 present,10.663178443908691
 in,0.29374513030052185
 high,7.439517498016357
 quantities,4.893318176269531
 in,0.555231511592865
 a,5.40084981918335
 patient,2.1970877647399902
 with,1.2588742971420288
 diabetic,7.767989158630371
 ket,1.5396486520767212
o,0.23546457290649414
acid,0.005095633212476969
osis,0.004012426361441612
 (,5.759799957275391
D,2.67687726020813
KA,0.2505964934825897
),5.025641918182373
 that,8.3448486328125
 leads,5.724335670471191
 to,0.023247454315423965
 o,12.883575439453125
sm,1.7672609090805054
otic,0.11576788872480392
 di,9.80614948272705
ures,0.9033213257789612
is,0.0037659998051822186
?,0.5582272410392761
"
",0.22642993927001953
6,19.995758056640625
.,0.0013155790511518717
 What,1.9325205087661743
 is,1.0268840789794922
 the,0.6821659207344055
 most,6.307884693145752
 common,3.0152556896209717
 cause,1.9763145446777344
 of,0.09873054921627045
 hyp,3.3921494483947754
ocal,6.748518943786621
ce,0.10051750391721725
mia,2.8721387934638187e-05
 in,1.1959692239761353
 hospitalized,9.298870086669922
 patients,0.5340589880943298
?,1.1795880794525146
"
",0.2489795684814453
7,10.55544376373291
.,0.0013940767385065556
 In,6.914574146270752
 an,6.3165788650512695
 83,14.947760581970215
-,1.0757701396942139
year,0.22279416024684906
-,0.39272555708885193
old,0.006849275436252356
 man,2.7259066104888916
 with,0.8543473482131958
 a,4.442425727844238
 history,2.750837564468384
 of,0.006398335099220276
 chronic,5.0488810539245605
 kidney,1.223099708557129
 disease,0.04998508095741272
 (,3.5318634510040283
C,1.7011710405349731
K,0.016410088166594505
D,0.0024622257333248854
"),",0.36200663447380066
 what,3.5300920009613037
 might,7.018524646759033
 be,0.6415568590164185
 the,1.098659873008728
 best,4.560068130493164
 treatment,1.9484963417053223
 for,1.2844464778900146
 his,4.209206581115723
 hyper,3.587325096130371
k,1.4868013858795166
al,0.011286973021924496
emia,0.11438190937042236
?,0.23238955438137054
"
",0.24049018323421478
8,11.073463439941406
.,0.001419727224856615
 Why,4.9625396728515625
 would,6.850498676300049
 a,2.612931489944458
 patient,2.804626941680908
 with,0.8073435425758362
 diabetic,6.17169189453125
 ket,0.026340028271079063
o,0.0070862919092178345
acid,0.0023697162978351116
osis,0.0035090125165879726
 develop,3.4264228343963623
 hyper,2.0995726585388184
gly,2.352459669113159
ce,0.03998701646924019
mia,0.00039088353514671326
 and,4.864727020263672
 acidic,14.678117752075195
 blood,5.925623893737793
?,1.7351365089416504
"
",0.25520288944244385
9,9.730767250061035
.,0.0015553893754258752
 What,1.8403849601745605
 is,1.2643985748291016
 the,0.6336376070976257
 most,3.897761821746826
 common,1.4461491107940674
 cause,0.5331244468688965
 of,0.03113478794693947
 metabolic,8.664650917053223
 acid,1.2144523859024048
osis,0.0004420631448738277
 in,0.5674756765365601
 patients,1.699641466140747
 who,5.61961555480957
 present,9.145633697509766
 to,4.357550621032715
 an,5.6395344734191895
 emergency,2.14424991607666
 department,0.4304908514022827
 (,4.527253150939941
ED,0.20216475427150726
)?,0.4750121533870697
"
",0.17934441566467285
10,9.345592498779297
.,0.0013395065907388926
 In,4.5767502784729
 a,1.16905677318573
 patient,3.750366687774658
 with,0.18301920592784882
 hyp,6.190764904022217
ocal,0.0868024155497551
ce,0.017188986763358116
mia,0.0023524898570030928
",",0.7562733888626099
 what,1.2487289905548096
 are,4.345942974090576
 two,9.795193672180176
 potential,5.613879203796387
 sequel,11.83985710144043
ae,0.004232676699757576
?,0.9731378555297852
"
",0.30649325251579285
11,4.548538684844971
.,0.001447702175937593
 If,6.365053653717041
 a,3.0910346508026123
 patient,1.0485423803329468
 presents,5.949518203735352
 with,1.6120280027389526
 hyper,2.814267635345459
cal,3.584841251373291
ce,0.08475793153047562
mia,0.00037832543603144586
",",1.3979114294052124
 how,3.2602040767669678
 does,4.298213958740234
 the,1.9676361083984375
 provider,12.01850414276123
 know,2.8675308227539062
 if,1.8261114358901978
 it,4.174046516418457
 is,0.4510089159011841
 related,5.434238433837891
 to,0.04649444669485092
 mal,10.204032897949219
ign,3.345121383666992
ancy,0.11191025376319885
 or,1.831324815750122
 a,4.716170310974121
 par,12.477376937866211
athy,3.3278865814208984
roid,0.00042219317401759326
 problem,6.88293981552124
?,0.2305634468793869
"
",0.1949308216571808
"
",0.004103316459804773
I,12.193004608154297
 need,8.342358589172363
 a,5.097294330596924
 paragraph,11.83084774017334
 to,3.1852829456329346
 explain,2.155740737915039
 the,2.4684178829193115
 answer,9.658447265625
.,2.1218364238739014
 Thanks,7.274178981781006
!,2.931584596633911
"
",1.2495030164718628
"
",0.0011619526194408536
[,6.62023401260376
ST,13.403414726257324
UD,4.230408191680908
ENT,3.6437184810638428
],3.206465244293213
1,10.206565856933594
.,1.3756330013275146
 A,6.300288200378418
.,5.3862385749816895
 The,5.115766525268555
 information,11.098496437072754
 presented,4.364029407501221
 in,1.761124610900879
 the,3.2825136184692383
 case,9.281098365783691
 above,8.564143180847168
 shows,8.020149230957031
 that,0.8461339473724365
 there,4.783332347869873
 are,2.372243881225586
 two,2.101245164871216
 main,2.865922451019287
 categories,8.19235610961914
 of,0.1406085342168808
 products,13.827884674072266
 on,7.688526630401611
 which,4.669661521911621
 the,2.6186838150024414
 company,11.6793212890625
 was,8.246370315551758
 investing,9.225909233093262
 to,6.257165431976318
 build,8.138729095458984
 a,2.0791690349578857
 new,4.047868251800537
 plant,7.781068801879883
.,1.7313709259033203
 One,4.4344635009765625
 was,5.308581352233887
 high,8.621196746826172
-,1.2692266702651978
quality,2.653714418411255
",",3.862961769104004
 low,4.028645992279053
-,0.05932365357875824
priced,5.7779951095581055
",",2.0054750442504883
 and,2.217365264892578
 made,6.38461446762085
 up,6.3771843910217285
 85,18.66722869873047
 percent,3.652493715286255
 of,0.18572324514389038
 the,0.7279439568519592
 total,2.578577756881714
 market,5.930198669433594
 (,5.7115349769592285
product,11.171220779418945
 21,16.083415985107422
"),",4.554347515106201
 while,2.495812177658081
 the,0.2925960123538971
 other,0.17110319435596466
 was,0.777198314666748
 medium,10.634002685546875
 quality,4.320666790008545
 and,3.313844680786133
 had,7.493429183959961
 an,5.079989910125732
 even,7.840752601623535
 higher,1.7711918354034424
 percentage,4.0887932777404785
 in,6.407346248626709
 the,1.4207148551940918
 overall,9.000923156738281
 market,0.6178635954856873
 (,0.7218452095985413
30,10.558597564697266
 percent,0.48699256777763367
),2.4907455444335938
 but,6.128185749053955
 only,4.608851909637451
 constituted,12.161520004272461
 15,4.4893388748168945
 percent,0.08679154515266418
 of,0.39993953704833984
 the,0.47618645429611206
 entire,7.254416465759277
 sales,7.843672752380371
 volume,2.8384432792663574
 (,1.2632484436035156
product,0.6155627369880676
 48,8.051082611083984
).,0.35935643315315247
 In,4.323899745941162
 addition,3.040280818939209
",",0.2779352366924286
 the,1.3469021320343018
 company,2.3228907585144043
 was,2.6967110633850098
 looking,6.367635250091553
 to,1.6927145719528198
 increase,4.066969394683838
 its,1.591446042060852
 presence,6.564228534698486
 in,0.331815630197525
 the,1.3653193712234497
 low,8.435626029968262
-,0.24408464133739471
cost,1.9226804971694946
",",2.7124719619750977
 high,1.9373714923858643
-,0.08634696155786514
quality,2.136908531188965
 segment,7.14198637008667
 since,8.738603591918945
 this,4.681264877319336
 represented,8.30392074584961
 a,1.684093952178955
 growing,7.616236209869385
 share,4.31259822845459
 of,0.1637481153011322
 the,0.9652429819107056
 total,1.7290902137756348
 market,0.9253482818603516
 and,3.8950698375701904
 could,5.061315536499023
 allow,7.636565685272217
 the,2.74472713470459
 company,0.5516571998596191
 to,0.10838602483272552
 build,6.424380779266357
 stronger,8.327735900878906
 long,9.10915470123291
-,0.07589709758758545
term,0.19153960049152374
 relationships,2.4922494888305664
 with,0.30427202582359314
 customers,3.550352096557617
.,0.9989964962005615
 B,7.118921756744385
.,0.03472088649868965
 The,1.398078441619873
 case,7.314643859863281
 also,4.376023769378662
 provided,10.099945068359375
 several,7.25244140625
 possible,7.065253257751465
 scenarios,6.206151008605957
 for,1.93288254737854
 the,1.5403279066085815
 development,6.408535480499268
 of,0.12647993862628937
 the,2.9932308197021484
 two,9.648038864135742
 products,2.3725366592407227
 that,4.408520221710205
 are,3.297779083251953
 considered,6.103384494781494
 critical,7.2219109535217285
 in,3.272355794906616
 building,7.1185302734375
 new,7.126584529876709
 plants,0.9645043015480042
.,0.8483273386955261
 One,5.091818809509277
 involved,8.625382423400879
 expanding,8.221341133117676
 the,1.4438111782073975
 production,5.260242938995361
 of,1.593611717224121
 the,2.4828531742095947
 lower,6.860173225402832
-,0.48809272050857544
quality,2.8110761642456055
 product,1.6079834699630737
",",2.824352741241455
 while,1.9340629577636719
 another,3.0366315841674805
 suggested,8.07380199432373
 increasing,4.459558486938477
 capacity,8.431879043579102
 in,2.6619935035705566
 the,0.727029025554657
 area,9.110698699951172
 of,1.4438557624816895
 high,3.02057147026062
-,0.5703040361404419
volume,4.637137413024902
 but,10.553685188293457
 medium,9.463025093078613
-,0.12005317211151123
quality,1.1629012823104858
 production,4.951022624969482
.,0.7422615885734558
 C,2.5405495166778564
.,0.0015336102806031704
 The,1.157922625541687
 final,9.775362968444824
 information,7.915627479553223
 from,6.542571544647217
 the,0.4625527560710907
 case,0.4288797378540039
 above,6.123569488525391
 that,9.215909957885742
 is,3.852205753326416
 pertinent,6.358985900878906
 to,0.5653243064880371
 the,1.2572247982025146
 decision,6.49238395690918
 on,5.927917957305908
 where,8.118674278259277
 to,0.7117276787757874
 build,2.762371301651001
 a,2.014138698577881
 new,0.2876642346382141
 plant,0.15779978036880493
 was,2.962531805038452
 the,4.575301647186279
 fact,4.4244208335876465
 that,0.007072119973599911
 there,4.092557907104492
 were,1.4187968969345093
 two,3.1205341815948486
 potential,6.923470497131348
 sites,9.956330299377441
 for,1.2191965579986572
 building,6.073581218719482
 it,8.76914119720459
:,2.449230670928955
 one,3.909259080886841
 located,6.849820137023926
 near,4.165284156799316
 the,1.1151005029678345
 main,5.9867939949035645
 research,10.304301261901855
 and,3.362734317779541
 development,0.3964116871356964
 facility,2.5477030277252197
",",2.3876941204071045
 and,0.6472601294517517
 the,2.002640962600708
 other,0.0862402394413948
 close,7.1257500648498535
 to,0.04950613155961037
 the,0.7001050114631653
 existing,7.455860137939453
 plant,2.815504550933838
.,0.7053866982460022
 However,5.8295578956604
",",0.010933849029242992
 the,1.7132868766784668
 R,12.31666088104248
&,1.483562707901001
D,0.0034546207170933485
 facility,3.647777795791626
 had,4.584874153137207
 limited,7.12471866607666
 capacity,2.272263526916504
 because,5.8331451416015625
 of,1.1720749139785767
 a,3.648449420928955
 lack,1.9775218963623047
 of,0.002093945862725377
 space,5.688485622406006
",",3.0703933238983154
 while,4.747857570648193
 the,0.4323452413082123
 existing,5.91771125793457
 plant,0.8422708511352539
 already,9.35275650024414
 operated,8.15353012084961
 at,3.316910743713379
 90,9.763498306274414
 percent,0.15371958911418915
 of,3.1115572452545166
 its,2.07106614112854
 production,6.552793502807617
 capacity,0.7233474850654602
 and,3.530683994293213
 would,6.237320899963379
 not,2.960569143295288
 be,1.938468098640442
 able,0.8752095699310303
 to,0.0072935293428599834
 support,3.9354419708251953
 any,5.7667412757873535
 additional,2.117009401321411
 investments,7.385979652404785
 in,3.6948649883270264
 the,1.1445341110229492
 medium,9.75583553314209
-,0.3066733181476593
term,8.850979804992676
.,0.5501580238342285
 [/,21.12856674194336
ST,0.8873723149299622
UD,0.01443901564925909
ENT,0.004740139469504356
],0.08168775588274002
"
",3.9988884925842285
"
",0.0008849501027725637
In,6.704390525817871
 order,4.9244184494018555
 to,0.07475408166646957
 diagnose,11.790831565856934
 a,4.657795429229736
 disease,5.104625701904297
",",1.3799407482147217
 it,3.28962779045105
 is,0.3534771203994751
 important,1.4616634845733643
 that,3.539198398590088
 healthcare,12.135027885437012
 practitioners,5.488633632659912
 do,6.685049533843994
 an,5.950976848602295
 assessment,2.917008876800537
 of,0.5586603283882141
 a,5.131989002227783
 patient,0.7497466802597046
.,5.375957489013672
 The,2.917581081390381
 first,5.3829779624938965
 step,1.0957682132720947
 in,1.5894696712493896
 assessing,5.413806438446045
 the,2.635286808013916
 patient,1.8641331195831299
 is,0.8406869769096375
 taking,7.9308881759643555
 a,1.2385374307632446
 history,5.36554479598999
 (,6.829946994781494
patient,7.8061909675598145
�,14.170063972473145
�,14.1154203414917
s,5.088555335998535
 chief,15.626477241516113
 complaint,5.513376712799072
).,5.947133541107178
 It,5.43540096282959
 involves,8.188836097717285
 questions,11.104156494140625
